Migration and proliferation of vascular smooth muscle (VSM) cells occurs during development, wound healing, angiogenesis, and contributes to the progression of vascular disease. Ca2+ signals are known to regulate cell proliferation and motility, although this knowledge has not been well integrated into molecular models, due in part to lack of insight into Ca2+-dependent effector mechanisms and targets. Ongoing work funded by this grant has focused on the structure and function of one major Ca2+ signal effector, namely multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII). VSM cell migration and proliferation are properties of """"""""synthetic phenotype"""""""" cells that have not acquired, or have lost, differentiated contractile protein markers and function. VSM phenotype modulation between differentiated contractile and proliferative/migratory states are of considerable interest and clinical importance, but are incompletely understood. An emerging concept, consistent with results from the past funding period, is that disease- or injury-induced changes in Ca2+ signaling mechanisms and dynamics contributes to development of the migratory/proliferative VSM phenotype promoting vascular wall remodeling. The overall objective of this renewal is to test the concept that Ca2+ signaling via specific CaMKII isoforms, regulates VSM gene transcription and is a determinant of VSM phenotype. This concept will be tested by pursuing three aims: 1.) We will test the hypothesis that CaMKII regulates the co-repressors HDAC4 and HDAC5 in synthetic phenotype VSM. The transcription activator MEF2 will be tested as a CaMKII/HDAC4,5-dependent target affecting gene transcription. CaMKII isoform specificity in coupling to this regulatory pathway be tested. 2.) The function of CaMKII isozymes as regulators of the transcriptional repressor REST/NRSF expression and activity in VSM will be evaluated and HDAC4/5 will be tested as intermediaries. 3.) The function of CaMKII-dependent regulation of HDAC4/5 and REST in regulating VSM phenotype and vascular remodeling will be evaluated in vivo using the balloon-injured rat carotid artery as a model. By elucidating the functional consequences of CaMKII isoform modulation in response to vascular injury, the results of these studies are expected to provide insights into mechanisms underlying phenotypic modulation of VSM cells and mechanism(s) by which Ca2+ signals and a prominent Ca2+-dependent multifunctional protein kinase modulates VSM cell function and contributes to vascular disease.

Public Health Relevance

vascular smooth muscle (VSM) cell proliferation and migration is associated with pathological events such as atherosclerosis, cancer angiogenesis, and intimal hyperplasia associated with restenosis or transplant vasculopathy, all prevalent in Western society. By elucidating the mechanisms and functional consequences of CaMKII isoforms in regulating the transcriptional repressors, class IIa HDACs and REST, we expect to gain new insights into mechanisms by which Ca2+ signals modulate VSM cell phenotype and function. Knowledge of these mechanisms could provide new targets for therapeutics aimed at controlling vascular disease and restenosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL049426-16A1
Application #
7674461
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Goldman, Stephen
Project Start
1994-07-01
Project End
2014-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
16
Fiscal Year
2009
Total Cost
$392,500
Indirect Cost
Name
Albany Medical College
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
190592162
City
Albany
State
NY
Country
United States
Zip Code
12208
Jourd'heuil, Frances L; Xu, Haiyan; Reilly, Timothy et al. (2017) The Hemoglobin Homolog Cytoglobin in Smooth Muscle Inhibits Apoptosis and Regulates Vascular Remodeling. Arterioscler Thromb Vasc Biol 37:1944-1955
Zhao, Jinjing; Wu, Wen; Zhang, Wei et al. (2017) Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-?1/SMAD and myocardin/serum response factor. FASEB J 31:2576-2591
Zhao, Jinjing; Jourd'heuil, Frances L; Xue, Min et al. (2017) Dual Function for Mature Vascular Smooth Muscle Cells During Arteriovenous Fistula Remodeling. J Am Heart Assoc 6:
Lu, Yao Wei; Lowery, Anthony M; Sun, Li-Yan et al. (2017) Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina. Arterioscler Thromb Vasc Biol 37:1380-1390
Li, Jingjing; Miao, Lianjie; Zhao, Chen et al. (2017) CDC42 is required for epicardial and pro-epicardial development by mediating FGF receptor trafficking to the plasma membrane. Development 144:1635-1647
Liu, Yong Feng; Spinelli, Amy; Sun, Li-Yan et al. (2016) MicroRNA-30 inhibits neointimal hyperplasia by targeting Ca(2+)/calmodulin-dependent protein kinase II? (CaMKII?). Sci Rep 6:26166
Li, Jingjing; Miao, Lianjie; Shieh, David et al. (2016) Single-Cell Lineage Tracing Reveals that Oriented Cell Division Contributes to Trabecular Morphogenesis and Regional Specification. Cell Rep 15:158-170
Zhao, Jinjing; Zhang, Wei; Lin, Mingyan et al. (2016) MYOSLID Is a Novel Serum Response Factor-Dependent Long Noncoding RNA That Amplifies the Vascular Smooth Muscle Differentiation Program. Arterioscler Thromb Vasc Biol 36:2088-99
Saddouk, Fatima Z; Sun, Li-Yan; Liu, Yong Feng et al. (2016) Ca2+/calmodulin-dependent protein kinase II-? (CaMKII?) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling. FASEB J 30:1051-64
Spinelli, Amy M; Liu, Yongfeng; Sun, Li-Yan et al. (2015) Smooth muscle CaMKII? promotes allergen-induced airway hyperresponsiveness and inflammation. Pflugers Arch 467:2541-54

Showing the most recent 10 out of 46 publications